United States Healthcare Equipment & Supplies

Hologic Inc (HOLX)

Track

Ticker: HOLX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hologic Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 20 Oct 2025
Value US$4,693,320.43 | Price 118.76 | Shares 63,476 (+7.3%)
Proposed sale 20 Oct 2025
Value US$624,554.50 | Price 333.70 | Shares 38,232
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-22 2025-10-20 PlS Planned sale
Stamoulis Christiana
Non-Executive Director
63,476 +7.3%
118.76
US$4,693,320 		63,476 +7.3% 118.76 US$4,693,320
2025-10-20 2025-10-20 PrS Proposed sale
Stamoulis Christiana

Director

Non-Executive Director
38,232
333.70
US$624,555 		38,232 333.70 US$624,555
2025-09-23 2025-09-22 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
39,495 -15.8%
466.68
US$1,913,776 		39,495 -15.8% 466.68 US$1,913,776
2025-09-23 2025-09-22 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
77,418 -5.7%
67.04
US$5,190,103 		77,418 -5.7% 67.04 US$5,190,103
2025-09-23 2025-09-22 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
22,240 -1.6%
66.13
US$1,470,731 		22,240 -1.6% 66.13 US$1,470,731
2025-09-22 2025-09-22 PrS Proposed sale
2.1
MACMILLAN STEPHEN P

Officer; Director

Executive Director
138,358
66.98
US$9,266,548 		138,358 66.98 US$9,266,548
2025-05-09 2025-05-07 B Purchase
4.1
Madaus Martin D
Non-Executive Director
5,445 +inf%
55.24
US$300,760 		5,445 +inf% 55.24 US$300,760
2024-12-06 2024-12-04 S Sale
3.2
Mitchell Essex D

Chief Operating Officer

Officer
24,856 -47.1%
76.34
US$1,897,482 		24,856 -47.1% 76.34 US$1,897,482
2024-12-04 2024-12-04 PrS Proposed sale
3.2
Mitchell Essex D

Officer

Officer
24,856
76.34
US$1,897,484 		24,856 76.34 US$1,897,484
2024-09-03 2024-08-29 PlS Planned sale
Oberton Karleen Marie

Chief Financial Officer

Officer
52,679 -38.5%
80.56
US$4,243,662 		52,679 -38.5% 80.56 US$4,243,662
2024-08-29 2024-08-29 PrS Proposed sale
Oberton Karleen Marie

Officer

Officer
52,679
80.56
US$4,243,657 		52,679 80.56 US$4,243,657
2024-08-08 2024-08-06 S Sale
2.2
Schnittker Brandon

Div. President, GYN Surgical

Officer
476 -11.3%
83.11
US$39,559 		476 -11.3% 83.11 US$39,559
2024-08-06 2024-08-06 PrS Proposed sale
2.2
Schnittker Brandon

Officer

Officer
476
83.11
US$39,559 		476 83.11 US$39,559
2024-08-05 2024-08-01 PlS Planned sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
5,093 -32.7%
81.99
US$417,570 		5,093 -32.7% 81.99 US$417,570
2024-08-01 2024-08-01 PrS Proposed sale
2.9
COHN BENJAMIN JORDAN

Officer

Officer
5,093
81.99
US$417,574 		5,093 81.99 US$417,574
2024-08-01 2024-07-30 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
20,228 -1.7%
82.32
US$1,665,169 		20,228 -1.7% 82.32 US$1,665,169
2024-08-01 2024-07-30 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
16,177 -1.4%
81.44
US$1,317,455 		16,177 -1.4% 81.44 US$1,317,455
2024-08-01 2024-07-30 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
7,634 -0.6%
80.60
US$615,300 		7,634 -0.6% 80.60 US$615,300
2024-07-30 2024-07-30 PrS Proposed sale
2.1
MACMILLAN STEPHEN P

Officer; Director

Executive Director
44,039
81.70
US$3,597,894 		44,039 81.70 US$3,597,894
2024-07-19 2024-07-17 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
3,672 -0.3%
80.13
US$294,223 		3,672 -0.3% 80.13 US$294,223
2024-07-19 2024-07-17 PlS Planned sale
Stamoulis Christiana
Non-Executive Director
9,039 -16.6%
79.50
US$718,600 		9,039 -16.6% 79.50 US$718,600
2024-07-17 2024-07-17 PrS Proposed sale
2.1
MACMILLAN STEPHEN P

Officer; Director

Executive Director
3,672
80.13
US$294,222 		3,672 80.13 US$294,222
2024-07-17 2024-07-17 PrS Proposed sale
Stamoulis Christiana

Director

Non-Executive Director
9,039
79.50
US$718,600 		9,039 79.50 US$718,600
2024-03-15 2024-03-14 S Sale
2.5
GARRETT SCOTT T
Non-Executive Director
16,441 -25.3%
75.50
US$1,241,296 		16,441 -25.3% 75.50 US$1,241,296
2024-03-14 2024-03-14 PrS Proposed sale
2.5
GARRETT SCOTT T

Director

Non-Executive Director
16,441
75.50
US$1,241,296 		16,441 75.50 US$1,241,296
2024-03-11 2024-03-08 PlS Planned sale
3.8
Dockendorff Charles J
Non-Executive Director
1,465 -48.2%
76.21
US$111,648 		1,465 -48.2% 76.21 US$111,648
2024-03-11 2024-03-08 S Sale
2.2
CRAWFORD SALLY
Non-Executive Director
9,039 -6.4%
76.40
US$690,607 		9,039 -6.4% 76.40 US$690,607
2024-03-08 2024-03-08 PrS Proposed sale
2.2
CRAWFORD SALLY

Director

Non-Executive Director
9,039
76.40
US$690,610 		9,039 76.40 US$690,610
2024-03-08 2024-03-08 PrS Proposed sale
3.8
Dockendorff Charles J

Director

Non-Executive Director
1,465
76.21
US$111,648 		1,465 76.21 US$111,648
2024-01-30 2024-01-29 PlS Planned sale
Oberton Karleen Marie

Chief Financial Officer

Officer
14,940 -12.6%
75.00
US$1,120,500 		14,940 -12.6% 75.00 US$1,120,500
2024-01-29 2024-01-29 PrS Proposed sale
Oberton Karleen Marie

Officer

Officer
14,940
75.00
US$1,120,500 		14,940 75.00 US$1,120,500
2024-01-04 2024-01-02 PlS Planned sale
3.8
Dockendorff Charles J
Non-Executive Director
16,017 -91.6%
72.00
US$1,153,224 		16,017 -91.6% 72.00 US$1,153,224
2024-01-02 2024-01-02 PrS Proposed sale
3.8
Dockendorff Charles J

Director

Non-Executive Director
16,017
72.00
US$1,153,224 		16,017 72.00 US$1,153,224
2023-12-13 2023-12-11 S Sale
2.5
GARRETT SCOTT T
Non-Executive Director
10,000 -17.5%
68.71
US$687,116 		10,000 -17.5% 68.71 US$687,116
2023-12-11 2023-12-11 PrS Proposed sale
2.5
GARRETT SCOTT T

Director

Non-Executive Director
10,000
68.71
US$687,116 		10,000 68.71 US$687,116
2023-12-01 2023-11-29 PlS Planned sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
47,711 -3.7%
70.41
US$3,359,188 		47,711 -3.7% 70.41 US$3,359,188
2023-11-29 2023-11-29 PrS Proposed sale
2.1
MACMILLAN STEPHEN P

Officer; Director

Executive Director
47,711
70.06
US$3,342,633 		47,711 70.06 US$3,342,633
2023-11-24 2023-11-21 S Sale
3.2
Mitchell Essex D

Div. President, GYN Surgical

Officer
7,500 -36.9%
71.85
US$538,890 		7,500 -36.9% 71.85 US$538,890
2023-11-21 2023-11-21 PrS Proposed sale
3.2
Mitchell Essex D

Officer

Officer
7,500
71.85
US$538,892 		7,500 71.85 US$538,892
2023-06-20 2023-06-15 S Sale
2.5
GARRETT SCOTT T
Non-Executive Director
10,000 -14.9%
79.72
US$797,240 		10,000 -14.9% 79.72 US$797,240
2023-06-15 2023-06-15 PrS Proposed sale
2.5
GARRETT SCOTT T

Director

Non-Executive Director
10,000
79.72
US$797,239 		10,000 79.72 US$797,239
2023-05-09 2023-05-09 PrS Proposed sale
2.2
Thornal Kevin R

Officer

Officer
72,041
84.99
US$6,122,598 		72,041 84.99 US$6,122,598
2023-05-09 2023-05-05 PlS Planned sale
3.2
Mitchell Essex D

Div. President, GYN Surgical

Officer
2,390 -24.9%
83.73
US$200,115 		2,390 -24.9% 83.73 US$200,115
2023-05-05 2023-05-05 PrS Proposed sale
3.2
Mitchell Essex D

Officer

Officer
2,390
83.73
US$200,115 		2,390 83.73 US$200,115
2023-02-09 2023-02-07 PlS Planned sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
9,128 -39.0%
85.28
US$778,445 		9,128 -39.0% 85.28 US$778,445
2022-12-16 2022-12-14 S Sale
0.9
Hellmann Elisabeth A

SVP, Human Resources

Officer
1,649 -16.2%
76.40
US$125,984 		1,649 -16.2% 76.40 US$125,984
2022-12-02 2022-11-30 S Sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
12,501 -0.5%
76.02
US$950,326 		12,501 -0.5% 76.02 US$950,326
2022-12-02 2022-11-30 S Sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
20,999 -0.9%
75.43
US$1,584,039 		20,999 -0.9% 75.43 US$1,584,039
2022-11-17 2022-11-15 S Sale
2.2
Thornal Kevin R

Group Pres, Global Diagnostics

Officer
12,490 -16.7%
75.30
US$940,509 		12,490 -16.7% 75.30 US$940,509
2022-11-17 2022-11-15 S Sale
2.2
Thornal Kevin R

Group Pres, Global Diagnostics

Officer
6,628 -9.6%
75.37
US$499,552 		6,628 -9.6% 75.37 US$499,552
2022-11-16 2022-11-14 S Sale
1.9
Griffin John M.

General Counsel

Officer
3,268 -1.9%
76.49
US$249,979 		3,268 -1.9% 76.49 US$249,979
2022-11-16 2022-11-14 S Sale
1.9
Griffin John M.

General Counsel

Officer
23,634 -12.1%
76.07
US$1,797,909 		23,634 -12.1% 76.07 US$1,797,909
2022-11-14 2022-11-11 S Sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
42,893 -1.7%
75.94
US$3,257,294 		42,893 -1.7% 75.94 US$3,257,294
2022-11-14 2022-11-11 S Sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
52,529 -2.1%
75.57
US$3,969,564 		52,529 -2.1% 75.57 US$3,969,564
2022-11-14 2022-11-11 S Sale
2.1
MACMILLAN STEPHEN P

Chairman, President and CEO

Executive Director
43,000 -1.7%
75.64
US$3,252,520 		43,000 -1.7% 75.64 US$3,252,520
2022-11-03 2022-11-01 PlS Planned sale
Oberton Karleen Marie

Chief Financial Officer

Officer
14,545 -10.3%
72.50
US$1,054,512 		14,545 -10.3% 72.50 US$1,054,512
2022-05-19 2022-05-17 S Sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
3,844 -22.1%
78.75
US$302,730 		3,844 -22.1% 78.75 US$302,730
2022-05-19 2022-05-17 S Sale
3.0
Verstreken Jan

Group President, International

Officer
6,500 -9.2%
78.80
US$512,168 		6,500 -9.2% 78.80 US$512,168
2022-05-17 2022-05-13 S Sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
3,842 -22.1%
75.49
US$290,033 		3,842 -22.1% 75.49 US$290,033
2022-05-17 2022-05-13 S Sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
3,210 -19.2%
75.49
US$242,333 		3,210 -19.2% 75.49 US$242,333
2022-05-05 2022-05-03 PlS Planned sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
2,178 -13.9%
74.18
US$161,564 		2,178 -13.9% 74.18 US$161,564
2022-02-28 2022-02-24 S Sale
1.9
Daugherty Sean S.

Group President, BSH & Surg.

Officer
2,179 -4.3%
71.14
US$155,016 		2,179 -4.3% 71.14 US$155,016
2021-11-23 2021-11-19 S Sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
2,570 -14.1%
75.79
US$194,791 		2,570 -14.1% 75.79 US$194,791
2021-05-12 2021-05-10 S Sale
1.9
Daugherty Sean S.

Group President, BSH & Surg.

Officer
4,001 -13.1%
65.02
US$260,149 		4,001 -13.1% 65.02 US$260,149
2021-02-09 2021-02-05 S Sale
3.2
Bebo Allison P

SVP, Human Resources

Officer
6,100 -14.6%
84.06
US$512,778 		6,100 -14.6% 84.06 US$512,778
2021-02-08 2021-02-04 PlS Planned sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
8,396 -33.5%
84.31
US$707,867 		8,396 -33.5% 84.31 US$707,867
2020-12-14 2020-12-10 S Sale
2.2
Thornal Kevin R

Div. President, Diagnostics

Officer
9,236 -21.8%
73.99
US$683,409 		9,236 -21.8% 73.99 US$683,409
2020-12-14 2020-12-10 S Sale
2.2
Thornal Kevin R

Div. President, Diagnostics

Officer
7,633 -18.7%
74.00
US$564,804 		7,633 -18.7% 74.00 US$564,804
2020-12-14 2020-12-10 S Sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
1,477 -8.2%
73.64
US$108,759 		1,477 -8.2% 73.64 US$108,759
2020-11-20 2020-11-18 S Sale
1.9
Griffin John M.

General Counsel

Officer
11,579 -7.9%
71.35
US$826,208 		11,579 -7.9% 71.35 US$826,208
2020-11-20 2020-11-18 S Sale
1.9
Griffin John M.

General Counsel

Officer
11,321 -7.2%
70.80
US$801,482 		11,321 -7.2% 70.80 US$801,482
2020-11-19 2020-11-17 S Sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
5,000 -21.5%
72.58
US$362,900 		5,000 -21.5% 72.58 US$362,900
2020-11-16 2020-11-12 S Sale
2.9
COHN BENJAMIN JORDAN

Principal Accounting Officer

Officer
6,542 -26.0%
70.60
US$461,846 		6,542 -26.0% 70.60 US$461,846
2020-11-06 2020-11-04 PlS Planned sale
Stamoulis Christiana
Non-Executive Director
11,146 -22.1%
74.00
US$824,804 		11,146 -22.1% 74.00 US$824,804
2020-09-23 2020-09-21 PlS Planned sale
Oberton Karleen Marie

Chief Financial Officer

Officer
15,000 -34.1%
62.50
US$937,500 		15,000 -34.1% 62.50 US$937,500
Explore more

More insider trading research around Hologic Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America